Analysts' ratings for AMETEK AME over the last quarter vary from bullish to bearish, as provided by 6 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 2 | 1 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 1 | 1 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $211.5, a high estimate of $225.00, and a low estimate of $186.00. This upward trend is evident, with the current average reflecting a 6.11% increase from the previous average price target of $199.33.
Deciphering Analyst Ratings: An In-Depth Analysis
A comprehensive examination of how financial experts perceive AMETEK is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Jamie Cook | Truist Securities | Raises | Buy | $222.00 | $221.00 |
| Andrew Obin | B of A Securities | Raises | Buy | $225.00 | $195.00 |
| Steve Barger | Keybanc | Raises | Overweight | $215.00 | $205.00 |
| Richard Eastman | Baird | Raises | Neutral | $186.00 | $166.00 |
| Brett Linzey | Mizuho | Raises | Outperform | $200.00 | $190.00 |
| Jamie Cook | Truist Securities | Raises | Buy | $221.00 | $219.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to AMETEK. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of AMETEK compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of AMETEK's stock. This analysis reveals shifts in analysts' expectations over time.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of AMETEK's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on AMETEK analyst ratings.
Delving into AMETEK's Background
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group (EIG) and electromechanical group (EMG). EIG sells a broad portfolio of analytical, test, and measurement instruments, while EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.
AMETEK's Financial Performance
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Over the 3 months period, AMETEK showcased positive performance, achieving a revenue growth rate of 5.28% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: AMETEK's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 19.91%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): AMETEK's ROE stands out, surpassing industry averages. With an impressive ROE of 3.62%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): AMETEK's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.3% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: AMETEK's debt-to-equity ratio is below the industry average. With a ratio of 0.24, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
The Basics of Analyst Ratings
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
